Ali Zarrinpar, MD, PhD

Trials

Studies that name Ali Zarrinpar, MD, PhD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 10:51 UTC. Open this list on ClinicalTrials.gov

• Ph2
  NCT05669339 · AD HOC Trial: Artificial Intelligence-Based Drug Dosing In Hepatocellular Carcinoma

  University of Florida · recruiting · Hepatocellular Carcinoma · principal investigator
• N/A
  NCT05432765 · AIIM Trial: Personalized Medicine Approach to Kidney Allograft Function

  University of Florida · not yet recruiting · Kidney Transplant Rejection
• Ph2
  NCT04942665 · Low Dose ICG for Biliary Tract and Tumor Imaging

  University of Florida · completed · Cholecystitis, Hepatocellular Carcinoma, Liver Metastases · principal investigator
• Ph2
  NCT03527238 · Optimizing Immunosuppression Drug Dosing Via Phenotypic Precision Medicine

  University of Florida · completed · Liver Transplant, Kidney Transplant
• N/A
  NCT02776111 · Microfluidics and Transcriptomics in Post Solid Organ Transplant Patients

  University of Florida · terminated · Immunosuppression · principal investigator

Grants

NIH projects from RePORTER, fetched 2026-11-12 10:51 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.

No NIH project could be tied to this name by a shared trial or a matching institution.

NIH grants that fund their trials

These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.

• Optimizing Immunosuppression Drug Dosing via Phenotypic Precision Medicine
  R21DK116140 · NIDDK · UNIVERSITY OF FLORIDA · PI ALI ZARRINPAR · fiscal years 2018 to 2019
  Named on NCT03527238